Medical device start-up superDimension raises $24.8m
The company has developed minimally-invasive devices that enable the diagnosis and potentially the treatment of distal lung disease.
The company has developed minimally-invasive devices that enable the diagnosis and potentially the treatment of distal lung disease.
A majority of the current funding, $15 million, is from a credit line from Oxford Finance, a US financial institution that specializes in life sciences funding.
The company also raised $9.8 million from existing investors, which include Medica , Oxford Bioscience Parters, OrbiMed Advisors LLC, and Pitango Venture Capital.
superDimension's technology was originally developed for the toy industry - navigation for toy planes - but subsequently the firm decided to focus on the medical device market.
Published by Globes [online], Israel business news - www.globes-online.com - on September 12, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010
RELATED
VIEWS
MOST POPULAR
MARKET PRICES
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options








